litlas
Log inCreate account

Mark Shaw

Active 1974–2025

Affiliations
National Museums ScotlandUniversity of ReadingThis corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
ORCID
0000-0002-6651-8801
29
Papers
3,419
Citations
21
h-index
26
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for Mark Shaw1976: 1 citations1979: 1 citations1980: 1 citations1983: 1 citations1985: 1 citations1986: 7 citations1987: 2 citations1988: 3 citations1989: 1 citations1992: 3 citations1993: 4 citations1994: 4 citations1995: 1 citations1997: 4 citations1998: 4 citations1999: 7 citations2000: 3 citations2001: 4 citations2002: 2 citations2003: 1 citations2004: 1 citations2005: 7 citations2007: 4 citations2009: 4 citations2010: 9 citations2011: 16 citations2012: 14 citations2013: 10 citations2014: 16 citations2015: 19 citations2016: 17 citations2017: 14 citations2018: 10 citations2019: 67 citations2020: 109 citations2021: 89 citations2022: 85 citations2023: 54 citations2024: 144 citations2025: 53 citations2026: 1 citations1977–1978: no citations, so these years are not shown1981–1982: no citations, so these years are not shown1984: no citations, so this year is not shown1990–1991: no citations, so these years are not shown1996: no citations, so this year is not shown2006: no citations, so this year is not shown2008: no citations, so this year is not shown

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

Fields

  • Medicine54.7%
  • Computer Science11.1%
  • Biochemistry, Genetics and Molecular Biology9.8%
  • Agricultural and Biological Sciences8.6%
  • Physics and Astronomy6%
  • Engineering5%
  • Other4.8%

Topics

  • Lung Cancer Diagnosis and Treatment12.9%
  • Advanced Radiotherapy Techniques12.4%
  • Prostate Cancer Treatment and Research11.4%
  • Prostate Cancer Diagnosis and Treatment9.6%
  • Renal cell carcinoma treatment8%
  • Hepatocellular Carcinoma Treatment and Prognosis6.9%
  • Other38.8%

Frequent coauthors

All papers

Open in search

Loading papers…

Mark Shaw | Litlas